Capricor Therapeutics
CAPR
#7367
Rank
NZ$1.00 B
Marketcap
NZ$17.24
Share price
-6.93%
Change (1 day)
72.10%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): NZ-$4.26

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$4.43. In 2025 the company made an earnings per share (EPS) of NZ-$4.09 a decrease over its 2024 EPS that were of NZ-$2.17.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$4.264.23%
2025NZ-$4.0988.33%
2024NZ-$2.17
2022NZ-$2.1335.63%
2021NZ-$1.57-7.45%
2020NZ-$1.70-55.45%
2019NZ-$3.82-59.81%
2018NZ-$9.50-1850%
2017NZ$0.54-102.94%
2016NZ-$18.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.08-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.61-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ-$10.93 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.87 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$13.66 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$52.98 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA